H-1B sponsorship profile: Asklepios BioPharmaceutical, Inc. Across U.S. Department of Labor LCA disclosures, Asklepios BioPharmaceutical, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 83.3% (5 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Asklepios BioPharmaceutical, Inc’s H-1B petitions range from $109,000 at the low end to $250,000 at the high end, with a petition-weighted average of $160,428. That range reflects the mix of occupations the company sponsors, led by Senior Scientist, Group Lead (2 petitions at $109,000 avg), followed by Director - Safety Operations, Quality, and Compliance and Scientist IV. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Asklepios BioPharmaceutical, Inc is headquartered in Research Triangle Park, NC under NAICS code 32541, and places H-1B workers across 2 states, most heavily in NC, MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Asklepios BioPharmaceutical, Inc ranks. By H-1B petition volume, Asklepios BioPharmaceutical, Inc is #23,486 of 119,880 employers nationally and #595 of 2,377 employers headquartered in NC. Both ranks are computed live from the same underlying petition counts, not a separate estimate.